

Active life: 2 Days.
Dosage: Adult dose is 0.5-2.5 mg per day orally.
Liver toxicity: No.
Aromatization rate: None.
Active substance: Letrozole 2.5 mg in tablet form.
Product description: .
Possible side effects: .
Mono-Femara trade names: Oreta, Letronat, Zaronil, Letrazole, Feofar, Letroxyl, Letoripe, Letz, Femara, Lets, Fempro, Fematroz, Trozet, Letzol, Letoval, Letroz, Oncolet, Momazol, Shantroz, Letocor, Feofer, Letrova, Letromina, Letrozol, Mamazol, Letros.
Aromatase Inhibitor for Post Cycle Therapy. Store Mono-Femara at 20°C-25°C (68°F-77°F). Protect from light. Keep away from children.
Please log in to write Mono-Femara review.